national stem-cell therapy logo

Unlocking the Potential of Exosomes in Brain Health: A Leap Forward by Kimera Labs

Kimera Exosome logo

In the ever-evolving field of regenerative medicine, Mesenchymal Stem Cells (MSCs) and their secreted exosomes represent a frontier of hope for conditions once deemed untreatable. Kimera Labs, a pioneer in MSC exosome research and production, has recently made headlines with its groundbreaking work on brain targeting of exosomes, as highlighted in Nature Scientific Reports. This […]

Vitti Labs Announces FDA Approval of Phase II IND Clinical Trial of Combination Mesenchymal Stem Cell and Exosome Treatment of Pulmonary Fibrosis Secondary to Novel Corona Virus Infection (COVID-19)

FDA Approved sign

LIBERTY, Mo., May 2, 2022 /PRNewswire/ — Vitti Labs, an AATB Accredited Tissue Bank focused on life Science Research, development, and manufacturing, announced today that the U.S. Food and Drug Administration (FDA) has approved their Investigational New Drug Application (IND) to move forward with Phase II Outpatient Clinical Trial using a combination of Umbilical Cord […]